|
|
Henry N. Ginsberg
J Clin Invest. 2000;
106(4):453
doi:10.1172/JCI10762
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(210)
| Title and authors |
Publication |
Year |
Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size : GH and lipoprotein particle size
Hideo Makimura, Meghan N. Feldpausch, Takara L. Stanley, Noelle Sun, Steven K. Grinspoon
|
Clinical Endocrinology
|
2012 |
The emerging role of HDL in glucose metabolism
Brian G. Drew, Kerry-Anne Rye, Stephen J. Duffy, Philip Barter, Bronwyn A. Kingwell
|
Nat Rev Endocrinol
|
2012 |
A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways
Konstantinos N. Aronis, Christos S. Mantzoros
|
Metabolism
|
2012 |
Dietary restriction, caloric value and the accumulation of hepatic fat
Leandro P Moura, Gabriella A Figueredo, Natália O Bertolini, Marilia Ceccato, Jessica R Pereira, Amanda Christine S Sponton, Maria Alice R de Mello
|
Lipids Health Dis
|
2012 |
Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency
James M. Backes, Thomas Dayspring, Thomas Mieras, Patrick M. Moriarty
|
Journal of Clinical Lipidology
|
2012 |
Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice
Woon-Seok Choi, Jung-Jin Lee, Yohan Kim, In-Su Kim, Wei-Yun Zhang, Chang-Seon Myung
|
Arch. Pharm. Res.
|
2011 |
Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study
Tohru Noguchi, Junji Kobayashi, Kunimasa Yagi, Atsushi Nohara, Naoto Yamaaki, Masako Sugihara, Naoko Ito, Rie Oka, Masa-aki Kawashiri, Hayato Tada, Mutsuko Takata, Akihiro Inazu, Masakazu Yamagishi, Hiroshi Mabuchi
|
Atherosclerosis
|
2011 |
Brown adipose tissue activity controls triglyceride clearance
Alexander Bartelt, Oliver T Bruns, Rudolph Reimer, Heinz Hohenberg, Harald Ittrich, Kersten Peldschus, Michael G Kaul, Ulrich I Tromsdorf, Horst Weller, Christian Waurisch, Alexander Eychmüller, Philip L S M Gordts, Franz Rinninger, Karoline Bruegelmann, Barbara Freund, Peter Nielsen, Martin Merkel, Joerg Heeren
|
Nat Med
|
2011 |
Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes
D. M. Maahs, K. Nadeau, J. K. Snell-Bergeon, I. Schauer, B. Bergman, N. A. West, M. Rewers, S. R. Daniels, L. G. Ogden, R. F. Hamman, D. Dabelea
|
Diabetic Medicine
|
2011 |
Pharmacological Properties of the Central Antihypertensive Agent, Moxonidine
Lincoln P. Edwards, Terry A. Brown-Bryan, Lancelot McLean, Paul Ernsberger
|
Cardiovascular Therapeutics
|
2011 |
|
